Q3 2025 Shaily Engineering Plastics Ltd Earnings Call Transcript
Key Points
- Shaily Engineering Plastics Ltd (BOM:501423) reported a robust top-line growth of 25% in Q3 FY25, reaching INR197.6 crores.
- The company improved its gross margins and EBITDA margins to 47.5% and 23.4%, respectively, driven by a 52% year-on-year increase in the Healthcare segment.
- Shaily Engineering Plastics Ltd successfully signed six additional contracts in the healthcare sector, enhancing its medical device business, which is expected to comprise 30% of revenues over the next three years.
- The company incorporated Shaily Innovations FZCO in Dubai to expand its global market reach, alongside existing subsidiaries in the UK.
- Exports accounted for 79% of total revenue in Q3 FY25, indicating strong international demand for the company's products.
- The Industrial segment experienced a year-on-year degrowth of 8%, with revenues declining to INR12 crores.
- Machine utilization rates were relatively low at 45% in Q3 FY25, though there are plans to increase this to 80% in the next two to three years.
- There is uncertainty regarding potential impacts from US tariffs, as the USA is a significant market for the company.
- The company faces challenges in accurately forecasting the size of healthcare contracts due to dependencies on customer success and regulatory approvals.
- The Consumer segment's growth, while positive, is not expected to maintain the 20% year-on-year increase seen in Q3 FY25, as new orders are relatively small.
Ladies and gentlemen, good day and welcome to Q3 and nine-months FY25 earning conference call of Shaily Engineering Plastics Limited.
(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Amit Sanghvi, Managing Director from Shaily Engineering Plastics Limited. Thank you and over to you, sir.
Thank you very much. Good afternoon and a very warm welcome to all the participants to the post-results earnings call of Shaily Engineering Plastics. I have with me Mr. Sanjay Shah, our Chief Strategy Officer and SGA, our Investor Relations Advisor.
I hope you've had a look at our investor presentation that is uploaded, both on our website as well as the stock exchange.
Let me start by giving some highlights on the operational performance of the quarter.
We delivered a robust top-line growth of 25% to INR197.6 cores in Q3 FY25. And have improved our gross margins and EBITDA margins
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
